Neurochem-NRMX says its Eprodisate PDUFA date extended by 3 months Wednesday, April 11, 2007 07:07 ET Neurochem Limited, a wholly owned subsidiary of Neurochem...
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of...
The enSonix@home device is undergoing QC testing for efficacy, overall performance and durability. Sign offs to start the manufacturing are expected within 30...